Find Federal Grants
Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDUL) (P50 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-24-005
Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)?
National Institutes of Health · RFA-AG-24-038
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
National Institutes of Health · RFA-AG-24-036
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-183
South Sudan (USAID)-Juba · 72066823RFA00001
Health Resources and Services Administration · HRSA-23-130
Advancing Psychedelics Research for Treating Addiction (R61/R33 Basic Experimental Study with Humans Required)
National Institutes of Health · RFA-DA-24-029
Advancing Psychedelics Research for Treating Addiction (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-24-028
Advancing Psychedelics Research for Treating Addiction (R61/R33 Clinical Trial Required)
National Institutes of Health · RFA-DA-24-024
Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
National Institutes of Health · PAR-23-151
Substance Abuse and Mental Health Services Adminis · FG-23-005
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Clinical Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-23-010
Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors Biostatistics Research Center (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DK-23-009
Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-24-023
Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-24-022
Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-24-021
Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed)
National Institutes of Health · RFA-AI-23-032
Analyzing Early Events in TB and TB/HIV Infection for Interventional Targets (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-23-029
Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
National Institutes of Health · RFA-NS-23-027
Early-Stage Therapy Development for Alzheimer's Disease-Related Dementias (ADRD) (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-24-010